This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- Has the market gotten too complacent about these new highs? Jim Cramer told his Mad Money viewers Friday he thinks that might be the case, and next week's game plan will be a difficult road for the bulls.

Cramer said the markets will be ruled by two macro-economic events next week -- the European Central Bank's decision on interest rates on Thursday and the U.S. non-farm payroll numbers on Friday. Whatever stocks may gain earlier in the week can be easily be undone by these two events.

Then there's the Apple (AAPL) Worldwide Developers Conference that kicks off on Monday. Cramer said this stock, which he owns for his charitable trust, Action Alerts PLUS, has created 300,000 jobs in the burgeoning app economy and this conference should help buoy the markets.

Then, on Tuesday, Cramer said he'll be watching Dollar General (DG). While he generally likes the dollar group, Cramer said he'd bet on Target (TGT) with its 3% yield and its new CEO.

Wednesday brings earnings from Brown-Forman (BFB) and PVH Corp (PVH). Cramer said he'd be a buyer of Forman but would take profits and lock in gains with PVH because the stock has had a nice move higher.

On Thursday, J.M. Smucker (SJM), Ciena (CIEN), Joy Global (JOY) and Zoe's Kitchen (ZOES) will all be reporting. Cramer said he wants to hear Smucker's thoughts on the recent wave of consolidation in the food stocks, but he'd avoid Joy Global. He was also not a fan of Ciena, preferring Cisco Systems (CSCO), but does approve of owning Zoe's over the long term.

Executive Decision: Tom Pike

For his "Executive Decision" segment, Cramer sat down with Tom Pike, CEO of Quintiles Transnational (Q), the company biotech firms turn to when they need to outsource their clinical trials. Quintiles just posted a 13-cents-a-share earnings beat on an 8.4% rise in revenue.

Pike said it's been an exciting year for Quintiles. He said there has been a ton of money flowing into biotech firms and that means more drugs that need testing and more business for Quintiles.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,001.22 -38.27 -0.22%
S&P 500 1,988.40 -3.97 -0.20%
NASDAQ 4,538.5510 +6.4470 0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs